Blood Screening Market Analysis Report By Product, By Application, By End Use, Segment Forecasts-2017-2027

This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2018 to 2027.

The increasing incidence of infectious diseases and the rise in the number of blood donations is expected to drive the market for Blood Screening.

Market Size – USD 1.87 Billion in 2019, Market Growth - CAGR of 12.7%, Market trends – Growing prevalence of new pathogens.

 The global Blood Screening Market is forecast to reach USD 4.86 Billion by 2027, according to a new report by Reports and Data. The primary driving factors for the growth of the blood screening market is an increase in the prevalence of infectious diseases, rise in healthcare awareness, growth in the number of blood donations, and surge in NAT (nucleic acid amplification test).

Moreover, support from the government for a better healthcare system and advancement in technology will propel the growth of the market. However, factors such as stringent regulatory approvals and lack of skilled professionals are hampering the industry’s demand.

Various factors are promoting the growth and demand for blood screening. One of these contributing factors is an increase in the rate of technological advancements in the healthcare industry. An increase in the demand for technologically advanced methods in context to sample extraction, preparation, testing, and amplification for nucleic acid-like RNA and DNA along with strategic agreements with manufacturers of renowned research institutions are promoting research activities, which is forecasted to have a positive impact on the market.

 Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3458

The report provides a complete analysis of the global Blood Screening market with important details about the key market players from insightful primary and secondary research data. The report also aims to benefit the user by providing constructive data to gain insight into the market growth, size, and investment approaches.

The key companies profiled in the market are:

Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Ortho-Clinical Diagnostics, Inc., Grifols, Siemens Healthcare GmbH, SOFINA S.A, and Thermo Fisher Scientific.

Further key findings from the report suggest

  • The reagent and kits segment held a significant share owing to the accessibility of a wide range of reagents and the need for specific, reliable, and fast detection of blood screening. The growing demand for blood transfusion for the treatment of blood disorders contributed to the demand of the industry.
  • Nucleic acid testing (NAT) is a kind of molecular method deployed for in cases such as blood donations to screen the blood so as to decrease the danger of TTIs (transfusion-transmitted infections) in the individual receiving the blood. The main application of the nucleic acid test is associated with detecting viral RNAs and DNAs in a blood sample.
  • Hospitals held a larger market share due to the high number of cases recorded there. The segment is forecasted to grow with a CAGR of xx% during the forecast period.

For the purpose of this report, Reports and Data have segmented the global Blood Screening Market on the basis of Product and Services, Technology, End-User, and region:

 Product and Services Outlook (Revenue, USD Billion; 2017-2027)

  • Reagents and Kits
  • NAT Reagents and Kits
    • Standards and Controls
    • Buffers, Nucleotides, and Solutions
    • Enzymes and Polymerases
    • Probes and Primers
    • Labeling and Detection Reagents
  • ELISA Reagents and Kits
    • Controls
    • Substrates
    • Immunosorbents
    • Conjugates
    • Sample Diluents and Wash Solutions
  • Instruments
  • Rental Purchase
  • Outright Purchase
  • Software and Services

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • ELISA
    • Fluorescent immunoassay
    • Chemiluminescent Immunoassay
    • Colorimetric Immunoassay
  • NAT
    • Transcription-Mediated Amplification
    • Real-time Polymerase Chain Reaction
  • Western Blot Assays
  • Rapid Tests
  • NGS

End-User Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals
  • Blood Banks

Browse Complete Report “Blood Screening Market” @ https://www.reportsanddata.com/report-detail/blood-screening-market

 The report further segments the market on the basis of key regions of the world and offers an assessment of the production and manufacturing capacity, import and export, production and consumption patterns, supply and demand ratio, and the presence of key players in each region. The Blood Screening market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East Africa.

In-depth regional analysis covers:

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • U.K.
  • France
  • BENELUX
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Rest of LATAM
  • Middle East Africa
  • Saudi Arabia
  • A.E.
  • Rest of MEA

The report includes primary and subjective research with a comprehensive study examined and validated by industry professionals and experts. The report further provides insights into the opportunities and threats that the industry may witness in the upcoming years, throughout the forecast period. The report also provides an insight into the growth in revenue along with CAGR throughout the forecast period. It also provides insights into lucrative opportunities to enable the businesses to capitalize on the emerging trends of the market.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3458

Highlights of the TOC:

  1. Report Overview

1.1 Research Scope

1.2 Key Blood Screening market segments

1.3 Major players

1.4 Market analysis by product

1.5 Market analysis by application

1.6 Report timeline

  1. Global Growth Trends

2.1 Global Blood screening market size

2.2 Latest Blood Screening market trends

2.3 Key growth trends

  1. Competitive Landscape

3.1 Global Blood screening market key players

3.2 Global Blood Screening size by manufacturers

3.3 Products of major players

3.4 Entry barriers in the Blood Screening market

3.5 Mergers, acquisitions, joint ventures, and strategic alliances

About Reports and Data                              

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Thank you for reading our report. For additional information on customization of the report, connect with us and we will make sure you get a report tailored to meet your needs.

Blood Screening  Market, Blood Screening  Market size, Blood Screening  Market share, Blood Screening  Market trends, Blood Screening  Market forecast, Blood Screening  Market analysis, Blood Screening  Market scope, Blood Screening  Market manufacturer, Blood Screening  Market vendors, Blood Screening  Market players, Blood Screening  Market top player, Blood Screening  Market key player, Blood Screening  Market prominent player, Blood Screening  Market major manufacturers, Blood Screening  Market report .